|
Jun 13
|
3 Growth Companies With High Insider Ownership And Up To 27% Earnings Growth
|
|
Jun 12
|
June 2025's Select Stocks That Could Be Trading Below Estimated Value
|
|
Jun 11
|
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
|
|
Jun 10
|
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
|
|
Jun 6
|
The most popular stocks and funds investors bought in May
|
|
Jun 4
|
Trending tickers: Nvidia, CrowdStrike, Him & Hers, Rémy Cointreau and WH Smith
|
|
Jun 3
|
Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers
|
|
Jun 3
|
Hims & Hers, Joby Aviation, Pinterest: Trending Tickers
|
|
Jun 3
|
IBD 50's Hims & Hers Erases Its 19% Acquisition-Tied Sprint
|
|
Jun 3
|
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
|
|
Mar 13
|
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
|
|
Mar 13
|
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
|
|
Mar 11
|
Define Ventures Appoints Carolyn Magill as Venture Partner
|
|
Mar 6
|
Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private
|
|
Mar 5
|
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
|
|
Mar 5
|
Healthcare Stock Could Be Good 'Buy the Dip' Play
|
|
Mar 5
|
3 Growth Stocks Insiders Are Betting On
|
|
Mar 3
|
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025
|
|
Feb 26
|
Hims & Hers Health Full Year 2024 Earnings: In Line With Expectations
|
|
Feb 25
|
Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings
|